Cboe Global Markets: A 24-Hour Trading Winner

Cboe Global Markets is positioned to benefit from expanded 23/5 and eventual 24/7 trading, with its high-margin SPX, 0DTE and VIX-linked index-options franchise accounting for 50-60% of net revenue. The company is cited as having EPS compounding potential of roughly 15% CAGR, while just 5% growth in index-options volume could add approximately $73M of high-margin net revenue. The central catalyst is increased adoption of around-the-clock derivatives trading.

Analysis

The investable issue is not simply longer trading hours but whether CBOE can monetize the migration of institutional hedging from OTC and futures venues into listed, centrally cleared index options. Incremental overnight liquidity should be disproportionately accretive because surveillance, matching and clearing costs scale far more slowly than volume; a sustained mid-single-digit increase in proprietary index-option activity could support upward revisions to operating-margin and EPS estimates rather than just a one-quarter revenue beat. The key competitive constraint is liquidity fragmentation: CME (ES futures/options), Nasdaq (NDX), and ICE can retain flow if market makers do not quote sufficiently tight overnight SPX markets.

Near term, the stock likely needs evidence that extended-hours participation is additive rather than cannibalizing regular-session volume. Watch monthly ADV by product, bid/ask spreads during non-U.S. hours, market-maker participation, and the mix of transaction versus market-data revenue over the next 1-3 months. A favorable catalyst path is an implementation date accompanied by named liquidity-provider commitments; a weak launch would expose the valuation to de-rating because index options carry a premium multiple based on durable growth and unusually high incremental margins.

Consensus may underappreciate the feedback loop between 0DTE adoption and volatility-event hedging: more continuous access can make SPX the default instrument for reacting to Asia/Europe macro shocks, potentially pulling activity from futures and OTC desks. The counterpoint is that 24-hour access may increase adverse-selection risk, widening spreads and reducing retail or smaller-institution participation; regulators could also focus on market-quality and investor-protection implications if overnight 0DTE volumes accelerate. This is a quality compounder setup, but the catalyst is operational execution, not a guaranteed demand step-change.

Key Decisions for Investors

• Accumulate CBOE on weakness ahead of extended-hours launch, sized as a 6-12 month long rather than a day-one event trade. Target a 10-15% upside from estimate revisions and multiple support if index-options ADV shows sustained 5%+ growth; reassess if two consecutive monthly reports show extended-hours activity merely shifting existing volume.
• Use CME as the primary competitive hedge: long CBOE / short CME in equal beta-adjusted dollars for the 3-6 month launch-validation window. The thesis is relative share gain in global equity-index risk transfer; exit if CME's equity-index futures/options volumes accelerate while CBOE's SPX mix or overnight spreads deteriorate.
• Set a monitoring trigger around market quality, not headline volume: require tight executable overnight SPX spreads and broad liquidity-provider participation before increasing exposure. Persistent spread widening or a regulatory consultation specifically targeting short-dated index options would falsify the incremental-margin thesis.
• Do not chase near-term calls absent launch timing and volume disclosures. If the shares rerate materially before those data are available, treat the position as a watch item: the missing variable is whether new hours create incremental institutional flow versus cannibalize daytime 0DTE trading.